Alectinib (INN, marketed as Alecensa) is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small-cell lung cancer (NSCLC)... Wikipedia

 

 

Manufacturer's Website: Alecensa                                                                                                       Average retail cost: $13,589/month

Search Terms: Alecensa, alectinib, anaplastic lymphoma kinase, ALK,non-small-cell lung cancer, NSCLC